Navigation Links
Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
Date:8/26/2008

INVESTMENT BANKING FIRM HAS STRONG BACKGROUND IN BIOTECHNOLOGY

SHANGHAI, China, Aug. 26 /PRNewswire-FirstCall/ -- Sinobiomed, Inc. ("Sinobiomed", or "the Company") (OTC Bulletin Board: SOBM) is pleased to announce that it has retained CB Capital Partners, Inc. as its financial advisor to evaluate strategic alternatives to maximize shareholder value.

"While we are extremely pleased with the results obtained from the work undertaken to date on our three marketed and seven pipeline drugs, four of which are moving towards commercial release, we feel this success is not yet represented in shareholder value," said Banjun Yang, Company President and CEO. "We have invested heavily in the respective successful development of our products; now we need assistance in developing our Company's share valuation."

These product developments include:

-- The patented recombinant malaria vaccine candidate (PfCP2.9), for which Sinobiomed is now in discussions to initiate Phase IIb clinical trials

-- The Phase IIb clinical trials of the Company's patented anti-bleeding agent, recombinant Batroxobin (rBAT). Should the product proceed to Phase III clinical trials, it is expected that international governments and organizations would show significant interest. The Company has already received indications of interest from global pharmaceutical companies for joint development, marketing and production.

-- Recent applications for a Chinese and an international patent for recombinant human kallikrein-1 (rhK1), and for a Chinese patent for an innovative recombinant multivalent tuberculosis vaccine.

-- Continuing penetration of Chinese market of Sinobiomed's commercialized products, which treat a wide range of diseases including hepatitis B and hepatitis C. China is home to nearly one third of the world's hepatitis carriers.

"Collectively, these developments have substantially increased the value of Sinobiomed, which has seen a dra
'/>"/>

SOURCE Sinobiomed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Yongye Biotechnology International Retains CCG Investor Relations
2. Shengtai Pharmaceutical Retains Grayling Global As Investor Relations Counsel
3. Vermillion Retains ThinkPanmure to Assist in the Evaluation of Potential Strategic Alternatives
4. Insmed Retains RBC Capital Markets as Strategic Financial Advisor
5. CellCyte Genetics Retains InCap Group to Advise on Business Strategy and Financing
6. AMDL, Inc. Retains Strategic Growth International Inc. as its Global Investor Relations Advisor
7. SPO Medical Retains American Capital Ventures for Investor Relations Services
8. Interleukin Genetics Retains Top Life Science Communications Firms
9. Dragon retains leading investor relations firm
10. NuRx Pharmaceuticals Retains Russo Partners for Investor Relations, Corporate Communications Counsel
11. Carrington Retains Milkie/Ferguson to Explore Financial Alternatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... (PRWEB) July 23, 2014 Last year, ... Systems , a leading global provider of data management ... with TrialMaster, a leading-edge system for electronic data capture ... of universal design and study execution tools added TrialMaster ... and much anticipated version of Transform for TrialMaster, is ...
(Date:7/23/2014)... 23, 2014  Having the right people at the ... accelerating business growth and achieving clinical and operational goals. ... Leadership Summit, July 20-22, 2014, in San ... executives and healthcare experts discussing how partnerships have positively ... President & Chief Executive Officer of Cape Regional Medical ...
(Date:7/23/2014)... de julio de 2014 ADB International ... ha anunciado hoy una asociación con Austen BioInnovation ... o el Instituto), para el propósito de llevar ... terapia de señal bioeléctrica (el E-QURE BST Device), ... que tiene una importante experiencia en cicatrización de ...
(Date:7/23/2014)... CA (PRWEB) July 23, 2014 ... cell therapy in the US aimed at improving the ... their newest clinical study for Parkinson’s disease. StemGenex ... of stem cell therapy are paramount when providing care ... clinical study makes stem cell therapy accessible to the ...
Breaking Biology Technology:Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 2Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 3MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes 2ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 2ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 3ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 4ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 5ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 6StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3
... Radi Medical Systems Sponsors Case Review with Drs. Morton Kern, Nico ... ... Oct. 19 The use,of fractional flow reserve (FFR) for optimizing ... Cardiovascular,Therapeutics symposium, TCT 2007, which will take place Oct. 20-25 in,Washington. ...
... /Xinhua-PRNewswire-FirstCall/ -- Simcere,Pharmaceutical Group (NYSE: SCR ), ... in the rapidly growing Chinese marketplace,announced today that ... results,on Monday, November 5, 2007, before the market ... Jinsheng Ren, and chief financial,officer, Frank Zhigang Zhao, ...
... BSX ) today announced financial results for the third,quarter ended ... per share (EPS) for the fourth quarter of 2007. Highlights ... at the mid-point of guidance, and adjusted ... one position in the worldwide drug-eluting stent (DES) ...
Cached Biology Technology:Use of Fractional Flow for Optimizing Patient Outcomes is Topic of Several Sessions at TCT 2007 2Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday, November 5, 2007 2Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday, November 5, 2007 3Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 2Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 3Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 4Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 5Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 6Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 7Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 8Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 9Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 10Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 11Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 12Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 13Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 14Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 15Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 16Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 17Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 18Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 19Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 20Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 21Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 22Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 23Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 24Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 25
(Date:7/23/2014)... 60 billion tons of carbon into the atmosphere each ... burning fossil fuels. This happens through a process called ... by carbon coming into the soil system from falling ... the underground activities of plant roots. , Short-term ... rate of soil respiration. As a result, scientists have ...
(Date:7/23/2014)... available in German . ... cells, drive metabolic processes and transmit signals. To perform ... Scientists at the Max Planck Institute for Developmental Biology ... constructed of similar amino acid chains even when their ... that exist today arose from common precursors. Presumably, in ...
(Date:7/23/2014)... blow fly Chrysomya megacephala is commonly found ... to determine the time of death, referred to as ... form of C. megacephala from Tamil Nadu ... features and molecular characterization through generation of DNA barcoding. ... the open access Biodiversity Data Journal . , ...
Breaking Biology News(10 mins):Climate change and the soil 2Protein evolution follows a modular principle 2Dead body feeding larvae useful in forensic investigations 2
... NEW YORK (Feb. 29, 2008) -- Teens who can ... ads are less likely to succumb to alcohol advertising ... a three-year study of inner-city middle school students by ... journal Addictive Behaviors (April print edition). Previous research has ...
... derives from the red jungle fowl, but new research from ... chicken are more complicated than that. The ... legs and found to their surprise that this genetic heredity ... The study is being published today in the Web ...
... discovered how roots find their way past obstacles to grow ... Science, also explains how germinating seedlings penetrate the soil without ... in the fuzzy coat of hairs on the roots of ... control mechanism that enables these hairs to find their way ...
Cached Biology News:Learning how to say 'no' to alcohol advertising and peer pressure works for inner-city adolescents 2Darwin was wrong about the wild origin of the chicken 2
... The Sciclone ALH 4000 workstation is the ... seeking to introduce automated liquid handling capabilities,into ... that need to support routine applications on ... and,integrated for walk-away automation even when ...
Cells are grown in triple flasks, roller bottles, or NUNC Factory. Viability and growth curves are generated from a parallel representative culture....
NovaScreen offers cell biology, cell culture and molecular biology services for companies who lack a cell culture facility....
... Life Sciences provides cost effective cell culture ... or monoclonal antibodies. Quality at a reasonable ... you require research or commercial product, we ... methods such as roller bottles, hollow fiber, ...
Biology Products: